Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
Joint Authors
Sathyapalan, Thozhukat
Kahal, Hassan
Atkin, Stephen L.
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-12-15
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk.
Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese.
Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS.
Weight reduction plays an integral part in the management of women with PCOS.
In this paper, current available weight reduction therapies in the management of PCOS are discussed.
American Psychological Association (APA)
Kahal, Hassan& Atkin, Stephen L.& Sathyapalan, Thozhukat. 2010. Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome. Journal of Obesity،Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-469163
Modern Language Association (MLA)
Kahal, Hassan…[et al.]. Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome. Journal of Obesity No. 2011 (2011), pp.1-6.
https://search.emarefa.net/detail/BIM-469163
American Medical Association (AMA)
Kahal, Hassan& Atkin, Stephen L.& Sathyapalan, Thozhukat. Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome. Journal of Obesity. 2010. Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-469163
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-469163
